Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines
about
Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice.Evaluation in mice of Brucella ovis attenuated mutants for use as live vaccines against B. ovis infection.Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine.Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness.Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.An oral vaccine based on U-Omp19 induces protection against B. abortus mucosal challenge by inducing an adaptive IL-17 immune response in mice.Analysis of the behavior of eryC mutants of Brucella suis attenuated in macrophages.A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infectionVaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.Nucleotide sequence and expression of the gene encoding the major 25-kilodalton outer membrane protein of Brucella ovis: Evidence for antigenic shift, compared with other Brucella species, due to a deletion in the gene.Deletion of purE attenuates Brucella melitensis infection in mice.Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosisSerological diagnostic potential of recombinant outer membrane proteins (rOMPs) from Brucella melitensis in mouse model using indirect enzyme-linked immunosorbent assay.Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.Meta-Analysis and Advancement of Brucellosis Vaccinology.Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infectionDifferent responses of macrophages to smooth and rough Brucella spp.: relationship to virulenceImmune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins.Putative ATP-binding cassette transporter is essential for Brucella ovis pathogenesis in mice.Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis.Characterization of Cell Envelope Multiple Mutants of and Assessment in Mice of Their Vaccine Potential
P2860
Q33637479-28C506E0-8463-43F8-B823-6E722881406DQ33755285-1061B104-658F-4064-B970-64A8CD7A64B2Q33767903-0C982A05-0FAB-4AE6-A978-A74548326C99Q33769058-54DF168C-2C3E-4191-9254-9B3CE0C09AEEQ33784161-E2C94703-AB96-44A8-B4ED-470398299D16Q33802696-9511AA56-8933-41D2-A220-9D58A68AAFDEQ34033308-7C65DD89-9C79-4A28-B3DD-F31BB23B6E16Q34033400-3B672AA4-C469-4A67-B110-AC9298ABCFB5Q34194709-87242A2E-3014-476A-9A4A-30BDF8759525Q34544752-067987FB-E5D8-4CEF-8B07-6D7C4A031EA6Q35443231-853E8BA0-F48A-4C99-82DC-9580E53B5E62Q35496410-7489D2D8-AC2C-4EB1-BF50-8BD358F4B2AFQ35498593-B3577246-838A-42CA-9E64-00DDDC89C887Q35503256-373DB594-B362-4FDE-B43C-9383DA5A90BEQ35830978-BDF7F3E7-5B58-4EC3-9E32-8A96AA8AF6EFQ35946874-FACA9DE6-7ED9-4FDC-82B3-A4BD131C0882Q36192841-A600DB44-D753-459F-A9CA-CE56C070B65DQ37033007-F03CBC68-C974-4BA1-871A-5B2EA0807532Q40574714-E0AA2ED6-0B72-4490-BC4A-60942650B7A0Q41931666-5EB3EB02-1FD8-4632-8737-E188885EB0C5Q42121198-F75C9C5E-AA1C-416E-8A4A-8D0AF3D7EA48Q43196650-105A5375-C6A8-4EAD-9A1D-BA1627DDA7A6Q57191762-2361E4D1-AE84-4A40-B010-109CB2C21F50
P2860
Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Protective immunity to Brucell ...... tion with subcellular vaccines
@ast
Protective immunity to Brucell ...... tion with subcellular vaccines
@en
type
label
Protective immunity to Brucell ...... tion with subcellular vaccines
@ast
Protective immunity to Brucell ...... tion with subcellular vaccines
@en
prefLabel
Protective immunity to Brucell ...... tion with subcellular vaccines
@ast
Protective immunity to Brucell ...... tion with subcellular vaccines
@en
P2093
P2860
P1476
Protective immunity to Brucell ...... tion with subcellular vaccines
@en
P2093
Jiménez de Bagüés MP
P2860
P304
P407
P577
1994-02-01T00:00:00Z